SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May–June 2021
dc.contributor.author | Julie R, Harris | |
dc.contributor.author | Daniel, Owusu | |
dc.contributor.author | Kevin, O’Laughlin | |
dc.contributor.author | Adam, L. Cohen | |
dc.contributor.author | Amen, Ben Hamida | |
dc.contributor.author | Jaymin, C. Patel | |
dc.contributor.author | Molly, M. Freeman | |
dc.contributor.author | Thomas, Nsibambi | |
dc.contributor.author | Rebecca, Nieves | |
dc.contributor.author | Barbara, J. Marston | |
dc.contributor.author | Samuel, Wasike | |
dc.contributor.author | Jennifer, S. Galbraith | |
dc.contributor.author | Amy, L. Boore | |
dc.contributor.author | Lisa, J. Nelson | |
dc.contributor.author | Guagliardo, John D. Klena, Ketan Patel, Marek Ma | |
dc.contributor.author | Sarah, Guagliardo Anne J | |
dc.contributor.author | John, D. Klena | |
dc.contributor.author | Ketan, Patel | |
dc.contributor.author | Marek Ma | |
dc.date.accessioned | 2022-12-16T11:13:08Z | |
dc.date.available | 2022-12-16T11:13:08Z | |
dc.date.issued | 2022-06 | |
dc.description.abstract | The SARS-CoV-2 Delta variant emerged shortly after COVID-19 vaccines became available in 2021. We describe SARS-CoV-2 breakthrough infections in a highly vaccinated, well-monitored US Embassy community in Kampala, Uganda. Defining breakthrough infection rates in highly vaccinated populations can help determine public health messaging, guidance, and policy globally. | en_US |
dc.identifier.citation | Harris, Julie R., Daniel Owusu, Kevin O'Laughlin, et al. 'SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, may-June 2021', Emerging Infectious Diseases, vol. 28/no. 6, (2022), pp. 1279-1280. | en_US |
dc.identifier.issn | 080-6040 | |
dc.identifier.issn | E1080-6059 | |
dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/6346 | |
dc.language.iso | en | en_US |
dc.publisher | U.S. National Center for Infectious Diseases | en_US |
dc.subject | COVID-19, respiratory infections, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2 , SARS, coronavirus disease | en_US |
dc.subject | Medicine: Internal medicine: Infectious and parasitic diseases | en_US |
dc.title | SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May–June 2021 | en_US |
dc.type | Article | en_US |